139 related articles for article (PubMed ID: 26202275)
1. Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery In Vitro.
Rønholt S; Kristensen M; Nielsen HM
Methods Mol Biol; 2015; 1324():261-77. PubMed ID: 26202275
[TBL] [Abstract][Full Text] [Related]
2. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
[TBL] [Abstract][Full Text] [Related]
3. Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation.
Kristensen M; de Groot AM; Berthelsen J; Franzyk H; Sijts A; Nielsen HM
Bioconjug Chem; 2015 Mar; 26(3):477-88. PubMed ID: 25611217
[TBL] [Abstract][Full Text] [Related]
4. Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin.
Kamei N; Kawano S; Abe R; Hirano S; Ogino H; Tamiwa H; Takeda-Morishita M
Eur J Pharm Biopharm; 2020 Oct; 155():77-87. PubMed ID: 32781024
[TBL] [Abstract][Full Text] [Related]
5. Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery.
Panou DA; Diedrichsen RG; Kristensen M; Nielsen HM
Methods Mol Biol; 2022; 2383():371-384. PubMed ID: 34766302
[TBL] [Abstract][Full Text] [Related]
6. Revealing the importance of carrier-cargo association in delivery of insulin and lipidated insulin.
Diedrichsen RG; Harloff-Helleberg S; Werner U; Besenius M; Leberer E; Kristensen M; Nielsen HM
J Control Release; 2021 Oct; 338():8-21. PubMed ID: 34298056
[TBL] [Abstract][Full Text] [Related]
7. Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption.
Boegh M; Baldursdóttir SG; Müllertz A; Nielsen HM
Eur J Pharm Biopharm; 2014 Jul; 87(2):227-35. PubMed ID: 24413146
[TBL] [Abstract][Full Text] [Related]
8. Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation.
Boegh M; García-Díaz M; Müllertz A; Nielsen HM
Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):136-43. PubMed ID: 25622791
[TBL] [Abstract][Full Text] [Related]
9. Second generation, arginine-rich (R-X'-R)(4)-type cell-penetrating α-ω-α-peptides with constrained, chiral ω-amino acids (X') for enhanced cargo delivery into cells.
Patil KM; Naik RJ; Vij M; Yadav AK; Kumar VA; Ganguli M; Fernandes M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4198-202. PubMed ID: 25096299
[TBL] [Abstract][Full Text] [Related]
10. Oral biodrug delivery using cell-penetrating peptide.
Khafagy el-S; Morishita M
Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
[TBL] [Abstract][Full Text] [Related]
11. Cell-Penetrating Peptides as Carriers for Oral Delivery of Biopharmaceuticals.
Kristensen M; Nielsen HM
Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):99-106. PubMed ID: 26525297
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
Birch D; Diedrichsen RG; Christophersen PC; Mu H; Nielsen HM
Eur J Pharm Sci; 2018 Jun; 118():144-153. PubMed ID: 29524592
[TBL] [Abstract][Full Text] [Related]
13. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.
Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M
Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330
[TBL] [Abstract][Full Text] [Related]
14. Intracellular delivery of nanoparticles with CPPs.
Sawant R; Torchilin V
Methods Mol Biol; 2011; 683():431-51. PubMed ID: 21053148
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
[TBL] [Abstract][Full Text] [Related]
16. Cell penetrating peptides: a comparative transport analysis for 474 sequence motifs.
Ramaker K; Henkel M; Krause T; Röckendorf N; Frey A
Drug Deliv; 2018 Nov; 25(1):928-937. PubMed ID: 29656676
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Cell-Penetrating Peptides as Versatile, Effective Absorption Enhancers: Relation to Molecular Weight and Inherent Epithelial Drug Permeability.
Kamei N; Yamanaka J; Oda Y; Kaneoka S; Koide Y; Haruna Y; Takahashi Y; Tamiwa H; Takeda-Morishita M
Pharm Res; 2020 Sep; 37(10):182. PubMed ID: 32888051
[TBL] [Abstract][Full Text] [Related]
18. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
Schimpel C; Teubl B; Absenger M; Meindl C; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
Mol Pharm; 2014 Mar; 11(3):808-18. PubMed ID: 24502507
[TBL] [Abstract][Full Text] [Related]
19. Effects of N-terminal and C-terminal modification on cytotoxicity and cellular uptake of amphiphilic cell penetrating peptides.
Soleymani-Goloujeh M; Nokhodchi A; Niazi M; Najafi-Hajivar S; Shahbazi-Mojarrad J; Zarghami N; Zakeri-Milani P; Mohammadi A; Karimi M; Valizadeh H
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):91-103. PubMed ID: 29258339
[TBL] [Abstract][Full Text] [Related]
20. Cell-penetrating peptides: breaking through to the other side.
Koren E; Torchilin VP
Trends Mol Med; 2012 Jul; 18(7):385-93. PubMed ID: 22682515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
